Dr Juliana Bottomley’s expertise embraces commercial clinical development and health outcomes in ‘blue chip’ pharmaceutical companies and in consultancy. She is the Managing Director of Amygdala, with more than 20 years’ experience in the health outcomes and market access field. Juliana and HJCL have worked together on several health technology appraisal projects, including product submissions to the National Institute for Health and Care Excellence and the Scottish Medicines Consortium. You can find out more here: Amygdala Ltd

Tweets

• Working on a diabetes advocacy project that includes CGM access right now. https://t.co/XMHzKgMjAh, Nov 9
• RT @healthywalks: ✅ Spend time in nature ✅ Keep active ✅ Connect with others We all get stressed every now and then, but heading out… https://t.co/wIKI0sFLBm, Nov 7
• RT @MedTechGroup: We’re delighted to announce that Secretary of State for Health and Social Care @MattHancock will address this year’… https://t.co/uJjV3tPHpi, Oct 31
• RT @Agility3Sim: Ever wondered how you can make use of your #BIM data to develop #3D #virtualenvironments? Have a read of our latest… https://t.co/4ScQ2FQFkA, Oct 31
Follow @HJCLTweet